Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
VTGN similar filings
- 24 Jul 20 Regulation FD Disclosure
- 30 Jun 20 VistaGen Therapeutics Reports Fiscal Year 2020 Results and Provides CNS Pipeline Update
- 26 Jun 20 Collaboration intended to support Phase 3 development and commercialization of PH94B in key Asian markets
- 1 Jun 20 VistaGen and Nuformix Announce Agreement to Develop Novel Patentable Cocrystalline Forms of AV-101 for Treatment of Multiple CNS Conditions
- 18 May 20 The Proposed Phase 2A Open-label Study will be Conducted in New York City
- 28 Apr 20 VistaGen Expands PH94B Clinical Development to Include Adjustment Disorder Related to COVID-19
- 27 Apr 20 Entry into a Material Definitive Agreement
Filing view
External links
